nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
B cell depletion therapy in rheumatic disease
|
Edwards, J.C.W. |
|
2006 |
20 |
5 |
p. 915-928 14 p. |
artikel |
2 |
Chemokine inhibition in inflammatory arthritis
|
Tak, Paul P. |
|
2006 |
20 |
5 |
p. 929-939 11 p. |
artikel |
3 |
Contemporary concepts of inflammation, damage and repair in rheumatic diseases
|
Luyten, Frank P. |
|
2006 |
20 |
5 |
p. 829-848 20 p. |
artikel |
4 |
Diversity of regulatory T cells to control arthritis
|
van Roon, Joel A.G. |
|
2006 |
20 |
5 |
p. 897-913 17 p. |
artikel |
5 |
Editorial Board/Aims and Scope
|
|
|
2006 |
20 |
5 |
p. iii- 1 p. |
artikel |
6 |
“From bench to bedside and back again- emerging opportunities”
|
Bresnihan, Barry |
|
2006 |
20 |
5 |
p. 827-828 2 p. |
artikel |
7 |
Index
|
|
|
2006 |
20 |
5 |
p. I1- 1 p. |
artikel |
8 |
Inhibition of angiogenic pathways in rheumatoid arthritis: potential for therapeutic targeting
|
Veale, Douglas J. |
|
2006 |
20 |
5 |
p. 941-947 7 p. |
artikel |
9 |
Is IL-1 a good therapeutic target in the treatment of arthritis?
|
Burger, Danielle |
|
2006 |
20 |
5 |
p. 879-896 18 p. |
artikel |
10 |
New cytokine targets in inflammatory rheumatic diseases
|
Connell, Laura |
|
2006 |
20 |
5 |
p. 865-878 14 p. |
artikel |
11 |
Spondyloarthropathy: disease at the crossroads of immunity
|
FitzGerald, Oliver |
|
2006 |
20 |
5 |
p. 949-967 19 p. |
artikel |
12 |
The role of mesenchymal cells in the pathophysiology of inflammatory arthritis
|
Meyer, Lars-Henrik |
|
2006 |
20 |
5 |
p. 969-981 13 p. |
artikel |
13 |
Treating very early rheumatoid arthritis
|
Raza, Karim |
|
2006 |
20 |
5 |
p. 849-863 15 p. |
artikel |
14 |
Understanding the role of tissue degrading enzymes and their inhibitors in development and disease
|
Cawston, Tim E. |
|
2006 |
20 |
5 |
p. 983-1002 20 p. |
artikel |
15 |
Update on the biology of the chondrocyte and new approaches to treating cartilage diseases
|
Goldring, Mary B. |
|
2006 |
20 |
5 |
p. 1003-1025 23 p. |
artikel |